Loading...
 
Toggle Health Problems and D

Each use of Remdesivir generates thousands of dollars of bonuses to US hospitals – Nov 2022


Are U.S. Hospitals Really Paid Bonuses to Use Remdesivir?

Trial Site News
U.S. hospitals get bonuses if they use any of the following
Convalescent plasma (EUA on August 23, 2020)
Remdesivir (approved October 22, 2020; approved for children and babies on April 25, 2022)
Baricitinib (EUA on November 19, 2020, later amended December 20, 2021)
Molnupiravir (EUA on December 22, 2021)
Paxlovid (EUA on December 23, 2021, revised on July 6, 2022, to allow pharmacists to prescribe the treatment)
Get bonus if use any of the above if COVID is just suspected

One of many examples: Bonus of $19,500 when remdesivir that cost the hospital $3,120 was used


40 early COVID treatments (bonuses given for ones in red)

https://c19early.com/#fpearly
Image


Only 6 early treatments costing <$20 that have >3 trials

https://c19early.com/#fpearly
Image


See also Cost to prevent a COVID death: 11 dollars of Vitamin D - Nov 2022

November 2022 https://c19early.org/
Image


Is there any way hospitals can be paid to treat COVID with Vitamin D?

Note: Cost to save 1 life: Vitamin D $11, Remdesivir $208,000


Created by admin. Last Modification: Friday November 18, 2022 18:07:57 GMT-0000 by admin. (Version 9)

Attached files

ID Name Comment Uploaded Size Downloads
18834 All early treatments Nov 2022.jpg admin 18 Nov, 2022 17:22 148.50 Kb 116
See any problem with this page? Report it (WORKS NOV 2021)